Log in to save to my catalogue

Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase i...

Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f46543465c6341a8b7a69de0fcd3d048

Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acid

About this item

Full title

Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acid

Publisher

Cham: Springer International Publishing

Journal title

EJNMMI radiopharmacy and chemistry, 2018-07, Vol.3 (1), p.10-10, Article 10

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
To study MMP activity in vivo in disease, several radiolabeled MMP inhibitors functioning as radiotracers have been evaluated by means of SPECT and PET. Unfortunately, most of them suffer from metabolic instability, mainly hepatobiliary clearance and insufficient target binding. The introduction of a fluorine atom into MMPIs could con...

Alternative Titles

Full title

Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acid

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f46543465c6341a8b7a69de0fcd3d048

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f46543465c6341a8b7a69de0fcd3d048

Other Identifiers

ISSN

2365-421X

E-ISSN

2365-421X

DOI

10.1186/s41181-018-0045-0

How to access this item